1.
Paller A, Eichenfield L, Silverberg J, Cork M, Bangert C, Irvine A, Weidinger S, Barbarot S, Fan H, Alderfer J, Koppensteiner H, Chittuluru K. Integrated Safety Analysis of Abrocitinib in 635 Adolescent Patients With Moderate-To-Severe Atopic Dermatitis With Over 1000 Patient-Years of Exposure. J of Skin [Internet]. 2024Mar.18 [cited 2024Oct.26];8(2):s379. Available from: https://skin.dermsquared.com/skin/article/view/2690